Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

Funkcja

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• Appetite regulation: Enhances satiety signaling, leading to reduced caloric intake.
• Kontrola wagi: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

Źródło i standaryzacja

• Źródło: Synthetic peptide, produced via solid-phase peptide synthesis.
• Normalizacja: Purity ≥98% (HPLC), peptide content 70-90%.
• Formularze: Lyophilized powder, acetate salt.
• Zastosowania: Research on obesity, type 2 diabetes, and metabolic disorders.

Dokumentacja i zaopatrzenie

• MOQ: 5 g
• Miesięczna wydajność: 1 kg
• Czas realizacji: 5-10 days after order
• Dokumentacja: certyfikat pochodzenia (COA), karta charakterystyki substancji niebezpiecznej (MSDS), karta techniczna produktu (TDS)
• Opakowanie: Sealed vials or custom packaging

Zapytanie ofertowe

• Nasz adres: 280 Main Street, Xi’an, Shaanxi, Chiny
• LyvBio Sp. z o.o. — E-mail: info@lyvbio.com